Advertisements


Mallinckrodt Acthar Gel study meets all primary, secondary outcome measures

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2019

AstraZeneca"s Calquence Meets Endpoint in 2nd CLL Study

AstraZeneca's (AZN) lymphoma drug, Calquence, meets the primary endpoint and a key secondary one in a phase III study for the first-line .....»»

Category: personnelSource: nytJun 7th, 2019

Novartis" phase III QUARTZ study meets primary, key secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 30th, 2019

Eli Lilly announces Taltz meets primary, secondary endpoints in COAST-X study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 22nd, 2019

AbbVie"s RA Candidate Meets Primary Endpoints in Phase III

AbbVie's (ABBV) rheumatoid arthritis candidate, upadacitinib, meets both primary and secondary endpoints in the fourth phase III SELECT study for the given indication. AbbVie Inc. ABBV has anno.....»»

Category: personnelSource: nytApr 10th, 2018

Eli Lilly: Taltz meets primary, secondary endpoints in COAST-W study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

KemPharm Stock Down Despite Positive Data on ADHD Candidate

KemPharm (KMPH) presents positive top-line results on ADHD candidate KP415, which meets both primary and secondary endpoints in a pivotal study. KemPharm, Inc. KMPH announced positive t.....»»

Category: dealsSource: nytJul 10th, 2018

Celgene says Phase 3 Otezla study meets primary, secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

XBiotech bermekimab study meets primary, secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018

Eli Lilly announces Taltz meets primary, secondary endpoints in SPIRIT-H2H study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

XBiotech announces bermekimab study meets primary, key secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 23rd, 2019

UPDATE: Minerva Neurosciences stock rallies after trial of insomnia treatment meets main goals

Minerva Neurosciences Inc. shares soared 34% in premarket trade Monday, after the company said its trial of Seltorexant as a treatment for insomnia met its primary and key secondary goals. The company said the Phase 2b trial of the drug met i.....»»

Category: topSource: marketwatch2 hr. 30 min. ago

Intec Pharma"s Accordion Pill meets primary endpoint in PK study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2019

J&J"s (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study

J&J's (JNJ) Tremfya meets the primary endpoint in a late stage study that evaluated the efficacy and safety of the drug.....»»

Category: dealsSource: nytJun 17th, 2019

Mallinckrodt Presents Encouraging Data on Acthar Gel for RA

Mallinckrodt (MNK) reports encouraging results from a phase IV study on Acthar for RA at the EUL.....»»

Category: dealsSource: nytJun 14th, 2019

Enanta says EDP-938 meets primary, secondary endpoints in Phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

Genentech Phase II study of Gazyva met primary, key secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2019

Avenue Therapeutics Phase 3 tramadol study achieves primary, secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2019

BioCryst Down Despite Hereditary Angioedema Study Meets Goal

BioCryst's (BCRX) phase III study on BCX7353 for the prevention of hereditary angioedema attacks meets the primary endpoint for both doses (110mg/150 mg). Shares depreciate despite this .....»»

Category: worldSource: nytMay 22nd, 2019

Mallinckrodt completes enrollment in Phase 4 Acthar Gel study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 23rd, 2019

Palatin says results of PL-8177 study met all primary,secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 4th, 2019